Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.
about
HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activityPotential use of rapamycin in HIV infectionRapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplificationNatural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewEvolution of foamy viruses: the most ancient of all retrovirusesCurrent Trends of HIV Recombination WorldwideEffect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and DarunavirDesign of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to ResistanceCrystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamicsAnalysis of HIV-1 protease gene reveals frequent multiple infections followed by recombination among drug treated individuals living in São Paulo and Santos, BrazilNovel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1DDevelopment of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in ChinaDevelopment of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors.Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virusRare HIV-1 Subtype J Genomes and a New H/U/CRF02_AG Recombinant Genome Suggests an Ancient Origin of HIV-1 in AngolaUse of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections.Pilot studies for development of an HIV subtype panel for surveillance of global diversity.Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.Impact of Genetic Variations in HIV-1 Tat on LTR-Mediated Transcription via TAR RNA InteractionHLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load.Molecular and epidemiological characterization of HIV-1 subtypes among Libyan patients.Joint estimation of CD4+ cell progression and survival in untreated individuals with HIV-1 infection.Diversity of HIV-1 subtype B: implications to the origin of BF recombinantsComparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopesA national study of the molecular epidemiology of HIV-1 in Australia 2005-2012The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.Worldwide distribution of HIV type 1 epitopes recognized by human anti-V3 monoclonal antibodies.T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizationsDo HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates.HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.Unique CRF01_AE Gag CTL epitopes associated with lower HIV-viral load and delayed disease progression in a cohort of HIV-infected Thais.HIV-1 Vpr redirects host ubiquitination pathway.The changing face of HIV in Latin America and the CaribbeanStructural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.Development of a novel in silico docking simulation model for the fine HIV-1 cytotoxic T lymphocyte epitope mapping.Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens.
P2860
Q21076115-B750F313-8618-45B0-992C-54539FC5BA6FQ24606795-599526B4-58F1-4050-9C71-11475F8322BDQ24634551-C96AFE79-CF9C-4A7B-B568-B6434F346B76Q26770401-22CD3FD1-6B6C-42A9-B501-E29181B4421DQ26852372-EFFBAF52-7E81-4C5B-A1B8-27B42303EB84Q26865754-4A2CCB47-A3E2-4649-9840-080D03F6C283Q27651021-7DE10463-4F05-4558-AC0E-64BBB58F29CAQ27664086-12229896-6BF8-4716-8C5E-524C401446EDQ27666159-8FC430C3-8152-4BB5-94ED-BF0B0E95B3DDQ28238412-4AA4C121-7BD9-4F75-BBBC-028BAC6C6B66Q28538304-68407929-B936-4F2D-83AC-A13EC38930D6Q28538687-E78F3273-3EFB-4CC5-97CB-79FCB4CE9021Q28547519-FF9A528D-8D63-4B5A-BD4F-A387B838CA1EQ30351993-92B50D24-5DFB-450A-AE50-6A897B203F10Q30376865-607959F1-FA7E-4CFB-AA06-4AD34F70DFCCQ30387160-62C174E0-7E7F-4DEF-9085-4FB119060B72Q30387664-13040C39-A46B-4E0D-B163-7557ED932DD7Q30514155-104F6FB0-74CA-4DFA-8D7E-86270968C341Q33476165-08F67F1F-92BC-493C-B1FD-1D50CCE81EFAQ33526340-B8E2B0C7-FE58-4565-A733-09CAEB895DB5Q33587964-66E71ABC-BBF5-47C3-BE34-27B833CA0300Q33612214-21B038DF-0816-42A4-A424-A9AE23C0C2FEQ33617645-1E18F108-8A6E-49EB-B0BB-F892BD5A22BDQ33631159-49F29F70-B1A4-4A4D-B8E5-2950B024C291Q33646675-5E014C95-CCA0-4F78-9ACF-8EE2502CDF92Q33648910-04B0821F-65C5-4437-B810-4DD6B49FCA96Q33657146-333B778F-9214-4331-87E1-ED2B750167B9Q33705883-3D3DD4AC-13A8-4A81-9BAA-E6BE50900162Q33786222-6B844AF2-CB5C-402F-907D-BB99CAD43B60Q33833624-7D972D31-9EDF-4B1D-9204-A593718D7A76Q33850909-C9F13803-6361-4D72-BC0A-8C3A08536A5FQ33851789-EC7630E0-8936-4EFB-BF4A-FC1B95AB23EAQ33874874-2862E62C-D467-4FBC-B4E0-C26F8AEAB43EQ33985956-6BDBC563-6E4B-44A6-909A-F79ABCB1E10AQ34059218-060E7231-5A1C-4E92-870D-B9EAF748AE52Q34060467-9ED9398C-295F-4C2E-8340-B128CC5AE340Q34280044-7BF75FBC-740F-4E80-BCFF-59D6BA01961AQ34358831-954B477B-BD16-49F9-B00A-AF87F2499248Q34358851-2EF39A0F-F79F-4690-8675-0BA09A299C08Q34389449-43AFF0FB-D23B-4BBC-B0CF-FBC1FCAE3145
P2860
Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human immunodeficiency virus t ...... and therapeutic implications.
@ast
Human immunodeficiency virus t ...... and therapeutic implications.
@en
type
label
Human immunodeficiency virus t ...... and therapeutic implications.
@ast
Human immunodeficiency virus t ...... and therapeutic implications.
@en
prefLabel
Human immunodeficiency virus t ...... and therapeutic implications.
@ast
Human immunodeficiency virus t ...... and therapeutic implications.
@en
P2860
P356
P1433
P1476
Human immunodeficiency virus t ...... and therapeutic implications.
@en
P2093
F M Buonaguro
M L Tornesello
P2860
P304
10209-10219
P356
10.1128/JVI.00872-07
P407
P577
2007-07-18T00:00:00Z